‘Pivotal’ new breast cancer drug can help stop tumours early

About 55,000 women are diagnosed with breast cancer in the UK every year and 11,500 will die from the disease, The Institute of Cancer Research said. - (Associated Press)

A new drug has been found to halt the growth of certain breast cancer tumours, offering hope to patients and delaying the need for chemotherapy - with one professor describing the drug as “a pivotal moment in breast cancer care”.

The Serena-6 trial revealed that camizestrant effectively stops cancer cells from using hormones to fuel their growth. According to scientists, this is the first global study demonstrating that early detection of cancer resistance through blood tests can significantly benefit patients.